Literature DB >> 35601973

Treatment of gliomas with temozolomide: Rather at sunrise or sunset?

Patrick Roth1.   

Abstract

Entities:  

Year:  2022        PMID: 35601973      PMCID: PMC9113313          DOI: 10.1093/nop/npac024

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


× No keyword cloud information.
  8 in total

Review 1.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

2.  Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma.

Authors:  Emily A Slat; Jasmin Sponagel; Luciano Marpegan; Tatiana Simon; Najla Kfoury; Albert Kim; Andrea Binz; Erik D Herzog; Joshua B Rubin
Journal:  J Biol Rhythms       Date:  2017-03-16       Impact factor: 3.182

3.  A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.

Authors:  Anna R Damato; Ruth G N Katumba; Jingqin Luo; Himachandana Atluri; Grayson R Talcott; Ashwin Govindan; Emily A Slat; Katherine N Weilbaecher; Yu Tao; Jiayi Huang; Omar H Butt; George Ansstas; Tanner M Johanns; Milan G Chheda; Erik D Herzog; Joshua B Rubin; Jian L Campian
Journal:  Neurooncol Pract       Date:  2022-01-31

4.  CLOCK:BMAL1 is a pioneer-like transcription factor.

Authors:  Jerome S Menet; Stefan Pescatore; Michael Rosbash
Journal:  Genes Dev       Date:  2014-01-01       Impact factor: 11.361

Review 5.  EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.

Authors:  Michael Weller; Martin van den Bent; Matthias Preusser; Emilie Le Rhun; Jörg C Tonn; Giuseppe Minniti; Martin Bendszus; Carmen Balana; Olivier Chinot; Linda Dirven; Pim French; Monika E Hegi; Asgeir S Jakola; Michael Platten; Patrick Roth; Roberta Rudà; Susan Short; Marion Smits; Martin J B Taphoorn; Andreas von Deimling; Manfred Westphal; Riccardo Soffietti; Guido Reifenberger; Wolfgang Wick
Journal:  Nat Rev Clin Oncol       Date:  2020-12-08       Impact factor: 66.675

6.  Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study.

Authors:  Anna R Damato; Jingqin Luo; Ruth G N Katumba; Grayson R Talcott; Joshua B Rubin; Erik D Herzog; Jian L Campian
Journal:  Neurooncol Adv       Date:  2021-03-02

Review 7.  Roles of circadian clocks in cancer pathogenesis and treatment.

Authors:  Yool Lee
Journal:  Exp Mol Med       Date:  2021-10-07       Impact factor: 8.718

8.  Circadian clock, cancer, and chemotherapy.

Authors:  Aziz Sancar; Laura A Lindsey-Boltz; Shobhan Gaddameedhi; Christopher P Selby; Rui Ye; Yi-Ying Chiou; Michael G Kemp; Jinchuan Hu; Jin Hyup Lee; Nuri Ozturk
Journal:  Biochemistry       Date:  2014-10-29       Impact factor: 3.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.